Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    2.

    Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study.

    Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, Kuller LH, Kronmal RA, Resnick HE, Psaty BM.

    Arch Intern Med. 2002 Jan 28;162(2):209-16.PMID: 11802755 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

    Rubins HB, Robins SJ, Collins D, Nelson DB, Elam MB, Schaefer EJ, Faas FH, Anderson JW.

    Arch Intern Med. 2002 Dec 9-23;162(22):2597-604.PMID: 12456232 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke.

    Kernan WN, Viscoli CM, Inzucchi SE, Brass LM, Bravata DM, Shulman GI, McVeety JC.

    Arch Intern Med. 2005 Jan 24;165(2):227-33.PMID: 15668371 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study.

    Meigs JB, Nathan DM, D'Agostino RB Sr, Wilson PW; Framingham Offspring Study.

    Diabetes Care. 2002 Oct;25(10):1845-50.PMID: 12351489 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease.

    Kanaya AM, Herrington D, Vittinghoff E, Lin F, Bittner V, Cauley JA, Hulley S, Barrett-Connor E.

    Ann Intern Med. 2005 May 17;142(10):813-20.PMID: 15897531 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis.

    Gerstein HC, Pogue J, Mann JF, Lonn E, Dagenais GR, McQueen M, Yusuf S; HOPE investigators.

    Diabetologia. 2005 Sep;48(9):1749-55. Epub 2005 Jul 30.PMID: 16059716 [PubMed - indexed for MEDLINE]Related articles

    10.

    Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose.

    Qiao Q, Pyörälä K, Pyörälä M, Nissinen A, Lindström J, Tilvis R, Tuomilehto J.

    Eur Heart J. 2002 Aug;23(16):1267-75.PMID: 12175663 [PubMed - indexed for MEDLINE]Related articles

    11.

    Postchallenge hyperglycemia and mortality in a national sample of U.S. adults.

    Saydah SH, Miret M, Sung J, Varas C, Gause D, Brancati FL.

    Diabetes Care. 2001 Aug;24(8):1397-402.PMID: 11473076 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria.

    Barzilay JI, Spiekerman CF, Wahl PW, Kuller LH, Cushman M, Furberg CD, Dobs A, Polak JF, Savage PJ.

    Lancet. 1999 Aug 21;354(9179):622-5.PMID: 10466662 [PubMed - indexed for MEDLINE]Related articles

    13.

    Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold.

    Andreozzi F, Succurro E, Mancuso MR, Perticone M, Sciacqua A, Perticone F, Sesti G.

    Diabetes Metab Res Rev. 2007 Oct;23(7):547-50.PMID: 17311284 [PubMed - indexed for MEDLINE]Related articles

    14.

    Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies.

    Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, Yazdi H, Booker L.

    Diabetes Res Clin Pract. 2007 Dec;78(3):305-12. Epub 2007 Jun 29. Review.PMID: 17601626 [PubMed - indexed for MEDLINE]Related articles

    15.

    Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

    Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A.

    Diabetes Care. 1999 Jun;22(6):920-4.PMID: 10372242 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose.

    Liao D, Shofer JB, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY.

    Diabetes Care. 2001 Jan;24(1):39-44.PMID: 11194238 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study.

    Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL.

    Arch Intern Med. 1999 Oct 11;159(18):2151-9.PMID: 10527292 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Impaired fasting glucose: how low should it go?

    Shaw JE, Zimmet PZ, Hodge AM, de Courten M, Dowse GK, Chitson P, Tuomilehto J, Alberti KG.

    Diabetes Care. 2000 Jan;23(1):34-9.PMID: 10857965 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Is there a glycemic threshold for mortality risk?

    Balkau B, Bertrais S, Ducimetiere P, Eschwege E.

    Diabetes Care. 1999 May;22(5):696-9.PMID: 10332668 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data